Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Neuroprotectin D1 and GPR37 protect against chemotherapy-induced peripheral neuropathy and the transition from acute to chronic pain

Pharmacological Research(2025)10.1016/j.phrs.2025.107746Source: DataRank Database

Neuroprotectin D1 and GPR37 protect against chemotherapy-induced peripheral neuropathy and the transition from acute to chronic pain is a research paper published in Pharmacological Research (2025). On theSindex it has a DataRank of 0. It has been cited 23 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access23 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 14.10)OA: goldTopics (58)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Sangsu Bang ORCID,Chen Ouyang ORCID,Yize Li ORCID,Aidan McGinnis ORCID,Qin Zhang ORCID

Live enrichment

PubMed:40287118 OpenAlex:https://openalex.org/W4409760757

National Institute of Neurological Disorders and Stroke

Grant: R01NS131812

U.S. Department of Defense

Grant: DE032394

U.S. Department of Defense

Grant: W81XWH2110756

U.S. Department of Defense

Grant: W81XWH2110885

U.S. Department of Defense

Grant: W81XWH-2210267

NIDCR NIH HHS

Grant: R03 DE032394

NINDS NIH HHS

Grant: RF1 NS131812

FWCI

14.10

Citation Percentile

1.0%

Citation Trend

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.1016/j.phrs.2025.107746

publisherhttps://doi.org/10.1016/j.phrs.2025.107746

publisherhttps://api.elsevier.com/content/article/PII:S1043661825001719?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1043661825001719?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40287118

Fields of Study

Pain Mechanisms and TreatmentsCancer Treatment and PharmacologyPain Management and Opioid UseAnimalsReceptors, G-Protein-CoupledDocosahexaenoic AcidsGanglia, SpinalPaclitaxelMice, KnockoutMice, Inbred C57BLMaleNeuralgiaChronic PainPeripheral Nervous System DiseasesAntineoplastic AgentsMiceHumansCells, CulturedMacrophagesHyperalgesiaSensory Receptor Cells

MeSH Terms

AnimalsAntineoplastic AgentsCells, CulturedDocosahexaenoic AcidsGanglia, SpinalHumansHyperalgesiaMacrophagesMaleMice, Inbred C57BLNeuralgiaPeripheral Nervous System DiseasesSensory Receptor CellsPaclitaxelMice, KnockoutReceptors, G-Protein-CoupledMiceChronic Pain

Keywords

MedicineChronic painPeripheral neuropathyAcute painChemotherapy-induced peripheral neuropathyChemotherapyTransition (genetics)AnesthesiaInternal medicinePhysical therapyEndocrinologyChemistryBiochemistryChemotherapy-induced peripheral neuropathy (CIPN)GPR37Nerve degenerationNeuroprotectin D1 (NPD1)Pain chronicitySpecialized pro-resolving mediator (SPM)

Sustainable Development Goals

SDG 0: Good health and well-beingSDG 0: Zero hunger